Goldman Sachs Group Inc X Biotech Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 47,182 shares of XBIT stock, worth $139,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,182
Previous 47,182
-0.0%
Holding current value
$139,186
Previous $152,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XBIT
# of Institutions
55Shares Held
4.55MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$3.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA461KShares$1.36 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$732,3960.0% of portfolio
-
State Street Corp Boston, MA230KShares$677,6000.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $89.8M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...